Daiwa Securities Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Hold |
332
| – | – | ﹤0.01% | 1186 |
|
|
2025
Q1 | $3K | Hold |
332
| – | – | ﹤0.01% | 1159 |
|
|
2024
Q4 | $3K | Hold |
332
| – | – | ﹤0.01% | 1186 |
|
|
2024
Q3 | $4K | Hold |
332
| – | – | ﹤0.01% | 1177 |
|
|
2024
Q2 | $5K | Hold |
332
| – | – | ﹤0.01% | 1188 |
|
|
2024
Q1 | $6K | Buy |
332
+87
| +36% | +$1.57K | ﹤0.01% | 1186 |
|
|
2023
Q4 | $3K | Hold |
245
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q3 | $3K | Hold |
245
| – | – | ﹤0.01% | 1186 |
|
|
2023
Q2 | $4K | Hold |
245
| – | – | ﹤0.01% | 1184 |
|
|
2023
Q1 | $2K | Hold |
245
| – | – | ﹤0.01% | 1197 |
|
|
2022
Q4 | $2K | Buy |
245
+125
| +104% | +$1.02K | ﹤0.01% | 1205 |
|
|
2022
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 1262 |
|
|
2022
Q2 | $0 | Hold |
120
| – | – | ﹤0.01% | 1343 |
|
|
2022
Q1 | $1K | Hold |
120
| – | – | ﹤0.01% | 1285 |
|
|
2021
Q4 | $1K | Hold |
120
| – | – | ﹤0.01% | 1318 |
|
|
2021
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 1256 |
|
|
2021
Q2 | $1K | Hold |
120
| – | – | ﹤0.01% | 1176 |
|
|
2021
Q1 | $1K | Hold |
120
| – | – | ﹤0.01% | 1186 |
|
|
2020
Q4 | $1K | Buy |
+120
| New | +$1K | ﹤0.01% | 1163 |
|
|
2020
Q2 | – | Sell |
-46,100
| Closed | -$366K | – | 1187 |
|
|
2020
Q1 | $366K | Buy |
+46,100
| New | +$366K | ﹤0.01% | 730 |
|
|
2018
Q4 | – | Sell |
-227
| Closed | -$1K | – | 1129 |
|
|
2018
Q3 | $1K | Hold |
227
| – | – | ﹤0.01% | 1126 |
|
|
2018
Q2 | $1K | Hold |
227
| – | – | ﹤0.01% | 1148 |
|
|
2018
Q1 | $2K | Buy |
+227
| New | +$2K | ﹤0.01% | 1109 |
|